Detalhe da pesquisa
1.
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.
BMC Cancer
; 18(1): 1185, 2018 Nov 29.
Artigo
Inglês
| MEDLINE | ID: mdl-30497432
2.
Proliferation Determined by Ki-67 Defines Different Pathologic Response to Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer.
Clin Breast Cancer
; 15(5): 343-7, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25752727
3.
The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: an old tool with an enduring prognostic value.
Clin Breast Cancer
; 13(2): 146-52, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23318089
4.
Targeted therapies in the treatment of germ cell tumors: the need for new approaches against "orphan" tumors.
Crit Rev Oncol Hematol
; 83(3): 444-51, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22230258
5.
Time to diagnosis of ewing tumors in children and adolescents is not associated with metastasis or survival.
J Clin Oncol
; 32(35): 4020, 2014 Dec 10.
Artigo
Inglês
| MEDLINE | ID: mdl-25385742
6.
Adjuvant high-dose interferon therapy for melanoma: nothing has really changed.
Melanoma Res
; 24(5): 522-3, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25185694